PharmaCann to Sell Colorado Retail Assets to Vireo Growth in $49 Million Share Deal

PharmaCann Inc. has agreed to sell a package of its retail cannabis assets in Colorado to Vireo Growth Inc. in a transaction valued at about $49 million in newly issued Vireo shares, according to a company press release. The deal includes leases for operational dispensaries, the necessary cannabis licenses and permits to operate in the state, as well as certain inventory, contracts, and intellectual property tied to the LivWell brand, one of PharmaCann’s established retail names.

Under the terms of the agreement, ownership of these assets will transfer to Vireo once the required state and local regulatory approvals are obtained. In the interim, PharmaCann and Vireo have put in place a management services agreement that allows a Vireo subsidiary to help operate the Colorado dispensaries through the closing process.

Vireo Growth, a medical and adult-use cannabis company founded in 2014, says the acquisition will deepen its presence in Colorado’s competitive market, expanding its retail footprint and positioning the company to serve a broader customer base. The transaction is expected to close in the first half of 2026, subject to conditions and approvals.

PharmaCann, one of the largest vertically integrated private cannabis operators in the U.S., continues to adjust its portfolio through strategic transactions as market dynamics evolve.